Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Merck
Johnson and Johnson
AstraZeneca
McKesson

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

TRISENOX Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Trisenox, and when can generic versions of Trisenox launch?

Trisenox is a drug marketed by Cephalon and is included in one NDA.

The generic ingredient in TRISENOX is arsenic trioxide. There are five drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the arsenic trioxide profile page.

Drug patent expirations by year for TRISENOX
Drug Prices for TRISENOX

See drug prices for TRISENOX

Recent Clinical Trials for TRISENOX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Orsenix LLCPhase 1
MedsenicPhase 2
FoveaPhase 2

See all TRISENOX clinical trials

Recent Litigation for TRISENOX

Identify potential future generic entrants

District Court Litigation
Case NameDate
Cephalon, Inc. v. Fresenius Kabi USA, LLC2015-11-19

See all TRISENOX litigation

Synonyms for TRISENOX
28380-38-3
856307-43-2
AC1L24QX
AI3-01163
Arsenic trioxide [JAN]
Arsenic trioxide [UN1561] [Poison]
Arsenic trioxide [USAN:JAN]
arsenic(3+); oxygen(2-)
Arsenious Acid Anhydride
Arsenous oxide [ISO]
Arsenox
C13619
Caswell No. 059
CCRIS 5455
DTXSID0020103
EC 215-481-4
EINECS 215-481-4
EPA Pesticide Chemical Code 007001
FT-0622486
HSDB 419
LS-761
Oxyde Arsenieux
RCRA waste no. P012
Rcra waste number P012
S7V92P67HO
SR-01000944371
SR-01000944371-1
Trixenox
Trixonex
UN 1561
UN1561
UNII-S7V92P67HO
Z3621

US Patents and Regulatory Information for TRISENOX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cephalon TRISENOX arsenic trioxide INJECTABLE;INJECTION 021248-001 Sep 25, 2000 DISCN Yes No   See Pricing   See Pricing   See Pricing
Cephalon TRISENOX arsenic trioxide INJECTABLE;INJECTION 021248-002 Oct 13, 2017 AP RX Yes Yes   See Pricing   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TRISENOX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cephalon TRISENOX arsenic trioxide INJECTABLE;INJECTION 021248-001 Sep 25, 2000   See Pricing   See Pricing
Cephalon TRISENOX arsenic trioxide INJECTABLE;INJECTION 021248-001 Sep 25, 2000   See Pricing   See Pricing
Cephalon TRISENOX arsenic trioxide INJECTABLE;INJECTION 021248-002 Oct 13, 2017   See Pricing   See Pricing
Cephalon TRISENOX arsenic trioxide INJECTABLE;INJECTION 021248-002 Oct 13, 2017   See Pricing   See Pricing
Cephalon TRISENOX arsenic trioxide INJECTABLE;INJECTION 021248-001 Sep 25, 2000   See Pricing   See Pricing
Cephalon TRISENOX arsenic trioxide INJECTABLE;INJECTION 021248-002 Oct 13, 2017   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for TRISENOX
Drugname Dosage Strength RLD Date
➤ Subscribe Injection 1 mg/mL ➤ Subscribe   See Pricing

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
McKesson
Harvard Business School
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.